Chemically-Sensitive Field Effect Transistor
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 12 of these applications claim priority to application 62/130,594, filed Mar 9, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,921,112 | Chemically-Sensitive Field Effect Transistors, Systems, and Methods for Manufacturing and Using the Same In force · Medium confidence | Paragraf USA Inc. | In force | Medium confidence | ||
| US 11,536,722 | Chemically-Sensitive Field Effect Transistors, Systems, and Methods for Manufacturing and Using the Same In force · Medium confidence | Nanomedical Diagnostics, Inc. | In force | Medium confidence | ||
| US 12,298,301 | Chemically-Sensitive Field Effect Transistors, Systems, and Methods for Manufacturing and Using the Same In force · Medium confidence | Nanomedical Diagnostics, Inc. | In force | Medium confidence | ||
| US 11,782,057 | Ic with Graphene Fet Sensor Array Patterned in Layers Above Circuitry Formed in a Silicon Based CMOS Wafer In force · Medium confidence | Cardea Bio, Inc. | In force | Medium confidence | ||
| US 9,618,474 | Graphene Fet Devices, Systems, and Methods of Using the Same for Sequencing Nucleic Acids In force · High confidence | Cardea Bio, Inc. | In force | High confidence | ||
| US 9,857,328 | Chemically-Sensitive Field Effect Transistors, Systems, and Methods for Manufacturing and Using the Same In force · High confidence | Cardea Bio, Inc. | In force | High confidence | ||
| US 9,859,394 | Graphene Fet Devices, Systems, and Methods of Using the Same for Sequencing Nucleic Acids In force · Medium confidence | Cardea Bio, Inc. | In force | Medium confidence | ||
| US 10,006,910 | Chemically-Sensitive Field Effect Transistors, Systems, and Methods for Manufacturing and Using the Same In force · High confidence | Cardea Bio, Inc. | In force | High confidence | ||
| US 10,020,300 | Graphene Fet Devices, Systems, and Methods of Using the Same for Sequencing Nucleic Acids In force · Medium confidence | Cardea Bio, Inc. | In force | Medium confidence | ||
| US 10,429,342 | Chemically-Sensitive Field Effect Transistor In force · High confidence | Cardea Bio, Inc. | In force | High confidence | ||
| 7 more patents in this group · Pro | ||||||
10 of 17 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 17.
12 of these are in force and held by Cardea Bio, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.